Endo Slumps to 2009 Low on Outlook, Dragging Down Pharma Stocks

Updated on

Endo International Plc slumped to a seven-year low after the painkiller maker cut its full-year earnings forecast to well below analysts’ predictions, dragging down stocks from other pharmaceuticals companies.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.